Click for best price
Postpemic Era Lung Cancer Liquid Biopsy Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. ?XYZResearch?released the ?Post-pandemic Era-Global Lung Cancer Liquid Biopsy Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate?, which aims to sort out the development status and trends of the Lung Cancer Liquid Biopsy industry at home and abroad, estimate the overall market scale of the Lung Cancer Liquid Biopsy industry and the market share of major countries, Lung Cancer Liquid Biopsy industry, and study and judge the downstream market demand of Lung Cancer Liquid Biopsy through systematic research, Analyze the competition pattern of Lung Cancer Liquid Biopsy, so as to help solve the pain points of various stakeholders in Lung Cancer Liquid Biopsy industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018- 2028) of Lung Cancer Liquid Biopsy Market by XYZResearch Include
NorthAmerica
Asia
Europe
Middle East & Africa
South America
Competitive Analysis; Who are the Major Players in Lung Cancer Liquid Biopsy Market?
RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
Major Type of Lung Cancer Liquid Biopsy Covered in XYZResearch report:
Exosomes and RNA
CTCs and ctDNA
Application Segments Covered in XYZResearch Market
Hospitals
Clinics
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
Post-pandemic Era-Global Lung Cancer Liquid Biopsy Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
91 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Post-pandemic Era-Global Lung Cancer Liquid Biopsy Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Exosomes and RNA -Product Introduction and Major Company
1.1.2 CTCs and ctDNA -Product Introduction and Major Company
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Five-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Sales (2018 & 2022 & 2026)
2.2 Regional Market Share in Terms of Revenue (2018 & 2022 & 2026)
2.3 Regional Market Share in Terms of Consumption (2018 & 2022 & 2026)
3 Global Lung Cancer Liquid Biopsy Market Assessment by Type
3.1 Global Lung Cancer Liquid Biopsy Sales by Type (2018-2028)
3.2 Global Lung Cancer Liquid Biopsy Revenue by Type (2018-2028)
3.3 North America Lung Cancer Liquid Biopsy Sales and Revenue by Type (2018-2028)
3.4 Asia Lung Cancer Liquid Biopsy Sales and Revenue by Type (2018-2028)
3.5 Europe Lung Cancer Liquid Biopsy Sales and Revenue by Type (2018-2028)
3.6 Middle East & Africa Lung Cancer Liquid Biopsy Sales and Revenue by Type (2018-2028)
3.7 South America Lung Cancer Liquid Biopsy Sales and Revenue by Type (2018-2028)
4 Historical & Forecast Global Lung Cancer Liquid Biopsy Market Assessment by Application
4.1 Global Lung Cancer Liquid Biopsy Consumption and Consumption in Different Application Field (2018-2028)
4.2 North America Lung Cancer Liquid Biopsy Consumption and Consumption in Different Application Field (2018-2028)
4.3 Asia Lung Cancer Liquid Biopsy Consumption and Consumption in Different Application Field (2018-2028)
4.4 Europe Lung Cancer Liquid Biopsy Consumption and Consumption in Different Application Field (2018-2028)
4.5 Middle East & Africa Lung Cancer Liquid Biopsy Consumption and Consumption in Different Application Field (2018-2028)
4.6 South America Lung Cancer Liquid Biopsy Consumption and Consumption in Different Application Field (2018-2028)
5 North America
5.1 US Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
5.2 Canada Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
5.3 Mexico Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
6 Asia
6.1 China Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
6.2 Japan Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
6.3 India Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
6.4 Korea Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
6.5 Southeat Asia Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
7 Europe
7.1 Germany Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
7.2 UK Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
7.3 France Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
7.4 Russia Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
7.5 Italy Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
8 Middle East and Africa
8.1 Saudi Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
8.2 UAE Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
8.3 Egypt Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
8.4 Nigeria Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
8.5 South Africa Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
9 South America
9.1 Brazil Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
9.2 Argentina Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
9.3 Colombia Lung Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2028)
10 Global Lung Cancer Liquid Biopsy Average Price Trend
10.1 Market Price for Each Type of Lung Cancer Liquid Biopsy in North America (2018-2028)
10.2 Market Price for Each Type of Lung Cancer Liquid Biopsy in Asia (2018-2028)
10.3 Market Price for Each Type of Lung Cancer Liquid Biopsy in Europe (2018-2028)
10.4 Market Price for Each Type of Lung Cancer Liquid Biopsy in Middle East & Africa (2018-2028)
10.5 Market Price for Each Type of Lung Cancer Liquid Biopsy in South America (2018-2028)
11 Value Chain
11.1 Lung Cancer Liquid Biopsy Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on Lung Cancer Liquid Biopsy Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.2.2 Post-pandemic Era
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors
12 Major Players of Global Lung Cancer Liquid Biopsy Market, Competitive Analysis
12.1 RainDanceTechnologies
12.1.1 RainDanceTechnologies Company Profiles and Company News
12.1.2 RainDanceTechnologies Product Introduction
12.1.3 RainDanceTechnologies Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
12.1.4 SWOT Analysis
12.2 Biocartis
12.2.1 Biocartis Company Profiles and Company News
12.2.2 Biocartis Product Introduction
12.2.3 Biocartis Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
12.2.4 SWOT Analysis
12.3 Qiagen
12.3.1 Qiagen Company Profiles and Company News
12.3.2 Qiagen Product Introduction
12.3.3 Qiagen Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
12.3.4 SWOT Analysis
12.4 Guardant Health
12.4.1 Guardant Health Company Profiles and Company News
12.4.2 Guardant Health Product Introduction
12.4.3 Guardant Health Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
12.4.4 SWOT Analysis
12.5 Cynvenio
12.5.1 MDxHealth Company Profiles and Company News
12.5.2 MDxHealth Product Introduction
12.5.3 MDxHealth Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
12.5.4 SWOT Analysis
12.6 Pathway Genomics
12.6.1 Pathway Genomics Company Profiles and Company News
12.6.2 Pathway Genomics Product Introduction
12.6.3 Pathway Genomics Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
12.6.4 SWOT Analysis
12.7 NeoGenomics Laboraories
12.7.1 NeoGenomics Laboraories Company Profiles and Company News
12.7.2 NeoGenomics Laboraories Product Introduction
12.7.3 NeoGenomics Laboraories Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
12.7.4 SWOT Analysis
12.8 Sysmex Inostics
12.8.1 Sysmex Inostics Company Profiles and Company News
12.8.2 Sysmex Inostics Product Introduction
12.8.3 Sysmex Inostics Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
12.8.4 SWOT Analysis
12.9 Cynvenio
12.9.1 Cynvenio Company Profiles and Company News
12.9.2 Cynvenio Product Introduction
12.9.3 Cynvenio Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
12.9.4 SWOT Analysis
12.10 Menarini Silicon Biosystems
12.10.1 Menarini Silicon Biosystems Company Profiles and Company News
12.10.2 Menarini Silicon Biosystems Product Introduction
12.10.3 Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
12.10.4 SWOT Analysis
12.11 Adaptive Biotechnologies
12.12 Biocept
12.13 Angle plc
13 Global Lung Cancer Liquid Biopsy Market, Competitive Landscape and Market Forecast
13.1 Key Companies Dominating the Global Lung Cancer Liquid Biopsy Market
13.2 Concentration Ratio (CR5) of Global Lung Cancer Liquid Biopsy Market (2018)
13.2.1 Market Share of Top 5 Players in Term of Revenue (2018)
13.3 Concentration Ratio (CR5) of Global Lung Cancer Liquid Biopsy Market (2022)
13.3.1 Market Share of Top 5 Players in Term of Revenue (2022)
14 Conclusion
15 Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure Product Introduction
Table Sales (K Units) and Revenue (Million USD) of Major Players (2018-2022)
Figure Global Lung Cancer Liquid Biopsy Sales Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Sales of Each Type (2018-2028)
Table Regional Market Share in Terms of Sales (2019-2026)
Figure Regional Market Share in Terms of Sales (2019 - 2020)
Table Regional Market Share in Terms of Revenue (2019-2026)
Figure Regional Market Share in Terms of Revenue (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Table Global Lung Cancer Liquid Biopsy Sales (K Unit) by Type (2018-2028)
Figure Global Lung Cancer Liquid Biopsy Sales (K Unit) and Growth Rate (2018-2028)
Figure Global Lung Cancer Liquid Biopsy Sales Market Share (%) by Type (2019 -2020)
Table Global Lung Cancer Liquid Biopsy Revenue (Million USD) by Type (2018-2028)
Figure Global Lung Cancer Liquid Biopsy Revenue (Million USD) and Growth Rate (2018-2028)
Figure Global Lung Cancer Liquid Biopsy Revenue Market Share (%) by Type (2019-2020)
Figure North America Lung Cancer Liquid Biopsy Sales (K Unit) by Type (2018-2028)
Figure North America Lung Cancer Liquid Biopsy Sales (K Unit) and Growth Rate (2018-2028)
Figure North America Lung Cancer Liquid Biopsy Revenue (Million USD) by Type (2018-2028)
Figure North America Lung Cancer Liquid Biopsy Revenue (Million USD) and Growth Rate (2018-2028)
Figure Asia Lung Cancer Liquid Biopsy Sales (K Unit) by Type (2018-2028)
Figure Asia Lung Cancer Liquid Biopsy Sales (K Unit) and Growth Rate (2018-2028)
Figure Asia Lung Cancer Liquid Biopsy Revenue (Million USD) by Type (2018-2028)
Figure Asia Lung Cancer Liquid Biopsy Revenue (Million USD) and Growth Rate (2018-2028)
Figure Europe Lung Cancer Liquid Biopsy Sales (K Unit) by Type (2018-2028)
Figure Europe Lung Cancer Liquid Biopsy Sales (K Unit) and Growth Rate (2018-2028)
Figure Europe Lung Cancer Liquid Biopsy Revenue (Million USD) by Type (2018-2028)
Figure Europe Lung Cancer Liquid Biopsy Revenue (Million USD) and Growth Rate (2018-2028)
Figure Middle East & Africa Lung Cancer Liquid Biopsy Sales (K Unit) by Type (2018-2028)
Figure Middle East & Africa Lung Cancer Liquid Biopsy Sales (K Unit) and Growth Rate (2018-2028)
Figure Middle East & Africa Lung Cancer Liquid Biopsy Revenue (Million USD) by Type (2018-2028)
Figure Middle East & Africa Lung Cancer Liquid Biopsy Revenue (Million USD) and Growth Rate (2018-2028)
Figure South America Lung Cancer Liquid Biopsy Sales (K Unit) by Type (2018-2028)
Figure South America Lung Cancer Liquid Biopsy Sales (K Unit) and Growth Rate (2018-2028)
Figure South America Lung Cancer Liquid Biopsy Revenue (Million USD) by Type (2018-2028)
Figure South America Lung Cancer Liquid Biopsy Revenue (Million USD) and Growth Rate (2018-2028)
Table Historical & Forecast Lung Cancer Liquid Biopsy Different Application Field Consumption (K Unit)
Figure Consumption (K Unit) and Growth Rate (2018-2028)
Figure Different Application Field Consumption Market Share (%) (2019-2020)
Table Historical & Forecast Lung Cancer Liquid Biopsy Different Application Field Consumption (K Unit)
Figure North America Lung Cancer Liquid Biopsy Consumption (K Unit) and Growth Rate (2018-2028)
Figure North America Lung Cancer Liquid Biopsy Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Lung Cancer Liquid Biopsy Different Application Field Consumption (K Unit)
Figure Asia Lung Cancer Liquid Biopsy Consumption (K Unit) and Growth Rate (2018-2028)
Figure Asia Lung Cancer Liquid Biopsy Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Lung Cancer Liquid Biopsy Different Application Field Consumption (K Unit)
Figure Europe Lung Cancer Liquid Biopsy Consumption (K Unit) and Growth Rate (2018-2028)
Figure Europe Lung Cancer Liquid Biopsy Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Lung Cancer Liquid Biopsy Different Application Field Consumption (K Unit)
Figure Middle East & Africa Lung Cancer Liquid Biopsy Consumption (K Unit) and Growth Rate (2018-2028)
Figure Middle East & Africa Lung Cancer Liquid Biopsy Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Lung Cancer Liquid Biopsy Different Application Field Consumption (K Unit)
Figure South America Lung Cancer Liquid Biopsy Consumption (K Unit) and Growth Rate (2018-2028)
Figure South America Lung Cancer Liquid Biopsy Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Lung Cancer Liquid Biopsy Different Application Field Consumption (K Unit)
Table US Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Canada Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Mexico Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table China Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Japan Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table India Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Korea Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Southeast Asia Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Germany Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UK Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table France Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Russia Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Italy Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Saudi Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UAE Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Egypt Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Nigeria Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table South Africa Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Brazil Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Argentina Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Colombia Lung Cancer Liquid Biopsy Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biopsy in China
Table Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biopsy in EU
Table Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biopsy in USA
Table Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biopsy in Japan
Table Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biopsy in India
Table Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biopsy in Southeast Asia
Table Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biopsy in South America
Figure Value Chain Structure of Lung Cancer Liquid Biopsy
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Lung Cancer Liquid Biopsy
Figure Cost Structure of Lung Cancer Liquid Biopsy in 2020
Table Distributors/Traders List
Table RainDanceTechnologies Profiles
Table RainDanceTechnologies Lung Cancer Liquid Biopsy Product Introduction
Figure RainDanceTechnologies Lung Cancer Liquid Biopsy Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure RainDanceTechnologies SWOT Analysis
Table Biocartis Profiles
Table Biocartis Lung Cancer Liquid Biopsy Product Introduction
Figure Biocartis Lung Cancer Liquid Biopsy Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Biocartis SWOT Analysis
Table Qiagen Profiles
Table Qiagen Lung Cancer Liquid Biopsy Product Introduction
Figure Qiagen Lung Cancer Liquid Biopsy Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Qiagen SWOT Analysis
Table Guardant Health Profiles
Table Guardant Health Lung Cancer Liquid Biopsy Product Introduction
Figure Guardant Health Lung Cancer Liquid Biopsy Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Guardant Health SWOT Analysis
Table MDxHealth Profiles
Table MDxHealth Lung Cancer Liquid Biopsy Product Introduction
Figure MDxHealth Medical Devices & Consumables Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure MDxHealth SWOT Analysis
Table Pathway Genomics Profiles
Table Pathway Genomics Lung Cancer Liquid Biopsy Product Introduction
Figure Pathway Genomics Lung Cancer Liquid Biopsy Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Pathway Genomics SWOT Analysis
Table NeoGenomics Laboraories Profiles
Table NeoGenomics Laboraories Lung Cancer Liquid Biopsy Product Introduction
Figure NeoGenomics Laboraories Lung Cancer Liquid Biopsy Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure NeoGenomics Laboraories SWOT Analysis
Table Sysmex Inostics Profiles
Table Sysmex Inostics Lung Cancer Liquid Biopsy Product Introduction
Figure Sysmex Inostics Lung Cancer Liquid Biopsy Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Sysmex Inostics SWOT Analysis
Table Cynvenio Profiles
Table Cynvenio Lung Cancer Liquid Biopsy Product Introduction
Figure Cynvenio Lung Cancer Liquid Biopsy Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Cynvenio SWOT Analysis
Table Menarini Silicon Biosystems Profiles
Table Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Product Introduction
Figure Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Menarini Silicon Biosystems SWOT Analysis
Table Adaptive Biotechnologies Profiles
Table Adaptive Biotechnologies Lung Cancer Liquid Biopsy Product Introduction
Figure Adaptive Biotechnologies Lung Cancer Liquid Biopsy Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Adaptive Biotechnologies SWOT Analysis
Table Biocept Profiles
Table Biocept Lung Cancer Liquid Biopsy Product Introduction
Figure Biocept Lung Cancer Liquid Biopsy Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Biocept SWOT Analysis
Table Angle plc Profiles
Table Angle plc Lung Cancer Liquid Biopsy Product Introduction
Figure Angle plc Lung Cancer Liquid Biopsy Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Angle plc SWOT Analysis
